1. Home
  2. CTBI vs AKBA Comparison

CTBI vs AKBA Comparison

Compare CTBI & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTBI
  • AKBA
  • Stock Information
  • Founded
  • CTBI 1903
  • AKBA 2007
  • Country
  • CTBI United States
  • AKBA United States
  • Employees
  • CTBI N/A
  • AKBA N/A
  • Industry
  • CTBI Major Banks
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTBI Finance
  • AKBA Health Care
  • Exchange
  • CTBI Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • CTBI 1.0B
  • AKBA 861.7M
  • IPO Year
  • CTBI N/A
  • AKBA 2014
  • Fundamental
  • Price
  • CTBI $55.55
  • AKBA $2.94
  • Analyst Decision
  • CTBI Buy
  • AKBA Strong Buy
  • Analyst Count
  • CTBI 3
  • AKBA 5
  • Target Price
  • CTBI $59.00
  • AKBA $6.90
  • AVG Volume (30 Days)
  • CTBI 61.8K
  • AKBA 2.9M
  • Earning Date
  • CTBI 10-17-2025
  • AKBA 11-06-2025
  • Dividend Yield
  • CTBI 3.81%
  • AKBA N/A
  • EPS Growth
  • CTBI 17.47
  • AKBA N/A
  • EPS
  • CTBI 5.08
  • AKBA N/A
  • Revenue
  • CTBI $253,839,000.00
  • AKBA $203,733,000.00
  • Revenue This Year
  • CTBI $20.43
  • AKBA $43.91
  • Revenue Next Year
  • CTBI $4.40
  • AKBA $32.09
  • P/E Ratio
  • CTBI $10.96
  • AKBA N/A
  • Revenue Growth
  • CTBI 12.25
  • AKBA 16.75
  • 52 Week Low
  • CTBI $44.60
  • AKBA $1.26
  • 52 Week High
  • CTBI $61.67
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • CTBI 45.10
  • AKBA 51.11
  • Support Level
  • CTBI $54.50
  • AKBA $2.66
  • Resistance Level
  • CTBI $56.53
  • AKBA $3.01
  • Average True Range (ATR)
  • CTBI 0.93
  • AKBA 0.12
  • MACD
  • CTBI -0.09
  • AKBA 0.04
  • Stochastic Oscillator
  • CTBI 30.00
  • AKBA 77.14

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: